{"id":43256,"date":"2024-10-31T12:11:13","date_gmt":"2024-10-31T11:11:13","guid":{"rendered":"https:\/\/www.satt.fr\/?p=43256"},"modified":"2024-10-31T12:11:52","modified_gmt":"2024-10-31T11:11:52","slug":"entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/","title":{"rendered":"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus"},"content":{"rendered":"<p><strong><span style=\"color: #c90f4c;\">En 2020, la SATT Conectus annon\u00e7ait la cr\u00e9ation de la startup Lamina Therapeutics, ancr\u00e9e sur une technologie innovante issue INSERM\/Universit\u00e9 de Strasbourg (UMR 1260 Nanom\u00e9decine r\u00e9g\u00e9n\u00e9rative) et dont le d\u00e9veloppement technologique a \u00e9t\u00e9 soutenu par Conectus. Une belle startup deeptech qui d\u00e9veloppe une innovation sant\u00e9 prometteuse, qui pourrait ouvrir de nouvelles voies th\u00e9rapeutiques dans le domaine de la r\u00e9g\u00e9n\u00e9ration de l\u2019os et du cartilage pour traiter notamment l\u2019arthrose. Aujourd&#8217;hui, Lamina franchit une nouvelle \u00e9tape.<\/span><\/strong><\/p>\n<p>Lamina Therapeutics d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de dispositifs m\u00e9dicaux implantables pour la m\u00e9decine r\u00e9g\u00e9n\u00e9rative.<\/p>\n<p>La startup Lamina Therapeutics a re\u00e7u l&#8217;approbation de l&#8217;Agence europ\u00e9enne des m\u00e9dicaments (EMA) et de l&#8217;Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) pour <strong>lancer le premier essai clinique de phase I chez l&#8217;homme dans l&#8217;arthrose du genou.<\/strong><\/p>\n<p><strong>Cet essai innovant, qui se d\u00e9roulera \u00e0 Strasbourg, en France, repr\u00e9sente une premi\u00e8re mondiale :<\/strong> la combinaison d&#8217;un dispositif th\u00e9rapeutique implantable et de cellules souches autologues (ATMP combin\u00e9) pour traiter l&#8217;arthrose avanc\u00e9e en r\u00e9g\u00e9n\u00e9rant \u00e0 la fois l&#8217;os sous-chondral et le cartilage. Un r\u00f4le de premier plan dans la mise au point de cette solution innovante pour restaurer la fonction articulaire et am\u00e9liorer la qualit\u00e9 de vie des patients atteintes d&#8217;arthrose.<\/p>\n<p><strong>Cette approche pionni\u00e8re offre un espoir \u00e0 des millions de patients dans le monde.<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #c90f4c;\"><strong><a href=\"https:\/\/www.conectus.fr\/sites\/default\/files\/2020-12\/CP_FR_CREATION%20STARTUP%20LAMINA_DEF.docx_.pdf\">D\u0116COUVRIR L&#8217;AVENTURE LAMINA THERAPEUTICS<\/a><br \/><a href=\"https:\/\/lamina.one\/technology\/\">D\u0116COUVRIR LE SITE WEB DE LAMINA THERAPEUTICS<\/a><\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En 2020, la SATT Conectus annon\u00e7ait la cr\u00e9ation de la startup Lamina Therapeutics, ancr\u00e9e sur une technologie innovante issue INSERM\/Universit\u00e9 de Strasbourg (UMR 1260 Nanom\u00e9decine r\u00e9g\u00e9n\u00e9rative) et dont le d\u00e9veloppement technologique a \u00e9t\u00e9 soutenu par Conectus. Une belle startup deeptech qui d\u00e9veloppe une innovation sant\u00e9 prometteuse, qui pourrait ouvrir de nouvelles voies th\u00e9rapeutiques dans le [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":43257,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[535,536,603],"tags":[],"class_list":["post-43256","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-reussites","category-actualite","category-startup"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT<\/title>\n<meta name=\"description\" content=\"En 2020, la SATT Conectus annon\u00e7ait la cr\u00e9ation de la startup Lamina Therapeutics, ancr\u00e9e sur une technologie innovante issue INSERM\/Universit\u00e9 de Strasbourg (UMR 1260 Nanom\u00e9decine r\u00e9g\u00e9n\u00e9rative) et dont le d\u00e9veloppement technologique a \u00e9t\u00e9 soutenu par Conectus. Une belle startup deeptech qui d\u00e9veloppe une innovation sant\u00e9 prometteuse, qui pourrait ouvrir de nouvelles voies th\u00e9rapeutiques dans le domaine de la r\u00e9g\u00e9n\u00e9ration de l\u2019os et du cartilage pour traiter notamment l\u2019arthrose. Aujourd&#039;hui, Lamina franchit une nouvelle \u00e9tape.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France MANDRY\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/\"},\"author\":{\"name\":\"France MANDRY\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"headline\":\"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus\",\"datePublished\":\"2024-10-31T11:11:13+00:00\",\"dateModified\":\"2024-10-31T11:11:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png\",\"articleSection\":[\"R\u00e9ussites\",\"Actualit\u00e9\",\"Startup\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/\",\"url\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/\",\"name\":\"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png\",\"datePublished\":\"2024-10-31T11:11:13+00:00\",\"dateModified\":\"2024-10-31T11:11:52+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"description\":\"En 2020, la SATT Conectus annon\u00e7ait la cr\u00e9ation de la startup Lamina Therapeutics, ancr\u00e9e sur une technologie innovante issue INSERM\/Universit\u00e9 de Strasbourg (UMR 1260 Nanom\u00e9decine r\u00e9g\u00e9n\u00e9rative) et dont le d\u00e9veloppement technologique a \u00e9t\u00e9 soutenu par Conectus. Une belle startup deeptech qui d\u00e9veloppe une innovation sant\u00e9 prometteuse, qui pourrait ouvrir de nouvelles voies th\u00e9rapeutiques dans le domaine de la r\u00e9g\u00e9n\u00e9ration de l\u2019os et du cartilage pour traiter notamment l\u2019arthrose. Aujourd'hui, Lamina franchit une nouvelle \u00e9tape.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png\",\"width\":785,\"height\":192,\"caption\":\"Lamina Therapeutics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\",\"name\":\"France MANDRY\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/france\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT","description":"En 2020, la SATT Conectus annon\u00e7ait la cr\u00e9ation de la startup Lamina Therapeutics, ancr\u00e9e sur une technologie innovante issue INSERM\/Universit\u00e9 de Strasbourg (UMR 1260 Nanom\u00e9decine r\u00e9g\u00e9n\u00e9rative) et dont le d\u00e9veloppement technologique a \u00e9t\u00e9 soutenu par Conectus. Une belle startup deeptech qui d\u00e9veloppe une innovation sant\u00e9 prometteuse, qui pourrait ouvrir de nouvelles voies th\u00e9rapeutiques dans le domaine de la r\u00e9g\u00e9n\u00e9ration de l\u2019os et du cartilage pour traiter notamment l\u2019arthrose. Aujourd'hui, Lamina franchit une nouvelle \u00e9tape.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/","twitter_misc":{"Written by":"France MANDRY","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/"},"author":{"name":"France MANDRY","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"headline":"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus","datePublished":"2024-10-31T11:11:13+00:00","dateModified":"2024-10-31T11:11:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/"},"wordCount":288,"image":{"@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png","articleSection":["R\u00e9ussites","Actualit\u00e9","Startup"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/","url":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/","name":"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png","datePublished":"2024-10-31T11:11:13+00:00","dateModified":"2024-10-31T11:11:52+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"description":"En 2020, la SATT Conectus annon\u00e7ait la cr\u00e9ation de la startup Lamina Therapeutics, ancr\u00e9e sur une technologie innovante issue INSERM\/Universit\u00e9 de Strasbourg (UMR 1260 Nanom\u00e9decine r\u00e9g\u00e9n\u00e9rative) et dont le d\u00e9veloppement technologique a \u00e9t\u00e9 soutenu par Conectus. Une belle startup deeptech qui d\u00e9veloppe une innovation sant\u00e9 prometteuse, qui pourrait ouvrir de nouvelles voies th\u00e9rapeutiques dans le domaine de la r\u00e9g\u00e9n\u00e9ration de l\u2019os et du cartilage pour traiter notamment l\u2019arthrose. Aujourd'hui, Lamina franchit une nouvelle \u00e9tape.","breadcrumb":{"@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2024\/10\/Lamina.png","width":785,"height":192,"caption":"Lamina Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/entree-en-phase-clinique-pour-lamina-therapeutics-propulsee-par-la-satt-conectus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Entr\u00e9e en phase clinique pour Lamina Therapeutics, propuls\u00e9e par la SATT Conectus"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e","name":"France MANDRY","url":"https:\/\/www.satt.fr\/en\/author\/france\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/43256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=43256"}],"version-history":[{"count":3,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/43256\/revisions"}],"predecessor-version":[{"id":43260,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/43256\/revisions\/43260"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/43257"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=43256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=43256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=43256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}